Version 1.89 release notes
Release notes
Changes to the NVC have been made since the last release v1.88 (2025-11-28). For your reference, please find a summary of the changes below:
Vaccine lots
- Refer to the 'Vaccine Lots' tab in the Excel workbook to view which specific vaccine lots are new. Column C contains a flag indicating whether a lot is new (marked as 'YES' or 'NO'). You can also find these flags in column N of the 'LotTradenameMapping' tab
Tradename
- 271421000087109 | [Inf] FLUZONE Trivalent| (updated Fr picklist)
Generics
- 120983009 | Neisseria meningitidis serogroup C antigen | (updated antigen mapping)
Antigen/Immunoglobulin/Antitoxin
- 871873006 | [Men-ACYW-135] Meningococcal A, C, Y and W-135 vaccine | (updated EN and FR display name)
- 61221000087105 | Monoclonal antibody to Human respiratory syncytial virus | (updated CHI version date)
- 61731000087103 | RSV (respiratory syncytial virus) mRNA | (updated CHI version date)
- 61751000087107 | RSV (respiratory syncytial virus) mRNA encoding surface glycoprotein F | (updated CHI version date)
Immunization healthcare provider occupation
- 56371000087100 | Pharmacy intern | (updated Fr display name)
- 46255001 | Pharmacist | (updated Fr display name)
Market authorization holder
- 227 new market authorization concept codes were added to the NVC after they were introduced in the Canadian SNOMED CT Reference Sets by Canada Health Infoway
Historical concepts
- 60591000087104 | [Pneu-C-21] Pneumococcal conjugate 21-valent vaccine | (antigen replaced by 1360050007 and generic replaced by 1360050007 )
Summary of changes
- Antigen / Immunoglobulin / Antitoxin: 4
- DIN: 1
- Healthcare role type: 2
- Market authorization holder: 227
- Tradename immunizing agent: 1
- Vaccine lot: 5
- Version:
- 1.7.1